Orally efficacious NR2B-selective NMDA receptor antagonists

被引：51

作者：

Claiborne, CF

McCauley, JA ^{[1
]}

Libby, BE

Curtis, NR

Diggle, HJ

Kulagowski, JJ

Michelson, SR

Anderson, KD

Claremon, DA

Freidinger, RM

Bednar, RA

Mosser, SD

Gaul, SL

Connolly, TM

Condra, CL

Bednar, B

Stump, GL

Lynch, JJ

Macaulay, A

Wafford, KA

Koblan, KS

Liverton, NJ

机构：

[1] Merck Res Labs, Dept Med Chem, W Point, PA 19486 USA

[2] Merck Sharp & Dohme Res Labs, Dept Med Chem, Ctr Res Neurosci, Harlow CM20 2QR, Essex, England

[3] Merck Res Labs, Dept Mol Pharmacol, W Point, PA 19486 USA

[4] Merck Sharp & Dohme Res Labs, Dept Pharmacol, W Point, PA 19486 USA

[5] Merck Sharp & Dohme Res Labs, Dept Pharmacol, Ctr Res Neurosci, Harlow CM20 2QR, Essex, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2003年 / 13卷 / 04期

关键词：

D O I：

10.1016/S0960-894X(02)01061-2

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A novel series of benzamidines as synthesized and shogun to exhibit NR2B-subtype selective NMDA antagonist activity. Compound 31 is orally active in a carrageenan-induced rat hyperalgesia model of pain and shows no motor coordination side effects. (C) 2003 Elsevier Science Ltd. All rights reserved.

引用

页码：697 / 700

页数：4

共 50 条

[21] Convenient method for 14C-labelling of a series of (E)-Styrylamidines as NR2B-selective NMDA receptor antagonist
Saemian, Nader
Esmailli, Kameh
Shirvani, Gholamhossein
Payehghadr, Mahmood
Javaheri, Mohsen
Arjomandi, Omid Khalili
JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2012, 292 (01) : 85 - 88
[22] Convenient method for 14C-labelling of a series of (E)-Styrylamidines as NR2B-selective NMDA receptor antagonist
Nader Saemian
Kameh Esmailli
Gholamhossein Shirvani
Mahmood Payehghadr
Mohsen Javaheri
Omid Khalili Arjomandi
Journal of Radioanalytical and Nuclear Chemistry, 2012, 292 : 85 - 88
[23] The synthesis of a benzamidine-containing NR2B-selective NMDA receptor ligand labelled with tritium or fluorine-18
Hamill, TG
McCauley, JA
Burns, HD
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2005, 48 (01): : 1 - 10
[24] NEU2000, AN NR2B-SELECTIVE, MODERATE NMDA RECEPTOR ANTAGONIST AND POTENT SPIN TRAPPING MOLECULE FOR STROKE
Cho, Sung Ig
Park, Ui Jin
Chung, Jun-Mo
Gwag, Byoung Joo
DRUG NEWS & PERSPECTIVES, 2010, 23 (09) : 549 - 556
[25] New benzoyl urea derivatives as novel NR2B selective NMDA receptor antagonists
Borza, I.
Greiner, I.
Kolok, S.
Galgoczy, K.
Ignacz-Szendrei, Gy.
Horvath, Cs.
Farkas, S.
Gati, T.
Hada, V.
Domany, Gy.
PHARMAZIE, 2006, 61 (09): : 799 - 800
[26] NR2B subtype-selective NMDA receptor antagonists: 2001-2004
McCauley, JA
EXPERT OPINION ON THERAPEUTIC PATENTS, 2005, 15 (04) : 389 - 407
[27] NR2B-selective conantokin peptide inhibitors of the NMDA receptor display enhanced antinociceptive properties compared to non-selective conantokins
Xiao, Cai
Huang, Yuanyuan
Dong, Mingxin
Hu, Jie
Hou, Shuangshuang
Castellino, Francis J.
Prorok, Mary
Dai, Qiuyun
NEUROPEPTIDES, 2008, 42 (5-6) : 601 - 609
[28] Ifenprodil, a NR2B-selective antagonist of NMDA receptor, inhibits reverse Na+/Ca2+ exchanger in neurons
Brittain, Matthew K.
Brustovetsky, Tatiana
Brittain, Joel M.
Khanna, Rajesh
Cummins, Theodore R.
Brustovetsky, Nickolay
NEUROPHARMACOLOGY, 2012, 63 (06) : 974 - 982
[29] Recent advances in the development of NR2B subtype-selective NMDA receptor antagonists
Layton, ME
Kelly, MJ
Rodzinak, KJ
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (07) : 697 - 709
[30] Identification and Characterization of Novel NMDA Receptor Antagonists Selective for NR2A-over NR2B-Containing Receptors
Bettini, Ezio
Sava, Anna
Griffante, Cristiana
Carignani, Corrado
Buson, Alberto
Capelli, Anna Maria
Negri, Michele
Andreetta, Filippo
Senar-Sancho, Sergio A.
Guiral, Lorena
Cardullo, Francesca
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 335 (03): : 636 - 644

← 1 2 3 4 5 →